Cargando…

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy

Detalles Bibliográficos
Autores principales: Thompson, AM, Bray, S, Johnson, AM, Quinlan, P, Nikloff, DM, Evans, DG, Clarke, R, Lawrence, HJ, Howell, A, Latif, A, Ferraldeschl, R, Hillman, G, Fontecha, M, Newman, WG
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875610/
http://dx.doi.org/10.1186/bcr2545
_version_ 1782181609756164096
author Thompson, AM
Bray, S
Johnson, AM
Quinlan, P
Nikloff, DM
Evans, DG
Clarke, R
Lawrence, HJ
Howell, A
Latif, A
Ferraldeschl, R
Hillman, G
Fontecha, M
Newman, WG
author_facet Thompson, AM
Bray, S
Johnson, AM
Quinlan, P
Nikloff, DM
Evans, DG
Clarke, R
Lawrence, HJ
Howell, A
Latif, A
Ferraldeschl, R
Hillman, G
Fontecha, M
Newman, WG
author_sort Thompson, AM
collection PubMed
description
format Text
id pubmed-2875610
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-28756102010-05-25 CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy Thompson, AM Bray, S Johnson, AM Quinlan, P Nikloff, DM Evans, DG Clarke, R Lawrence, HJ Howell, A Latif, A Ferraldeschl, R Hillman, G Fontecha, M Newman, WG Breast Cancer Res Poster Presentation BioMed Central 2010 2010-05-18 /pmc/articles/PMC2875610/ http://dx.doi.org/10.1186/bcr2545 Text en Copyright ©2010 BioMed Central Ltd.
spellingShingle Poster Presentation
Thompson, AM
Bray, S
Johnson, AM
Quinlan, P
Nikloff, DM
Evans, DG
Clarke, R
Lawrence, HJ
Howell, A
Latif, A
Ferraldeschl, R
Hillman, G
Fontecha, M
Newman, WG
CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
title CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
title_full CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
title_fullStr CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
title_full_unstemmed CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
title_short CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
title_sort cyp2d6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875610/
http://dx.doi.org/10.1186/bcr2545
work_keys_str_mv AT thompsonam cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT brays cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT johnsonam cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT quinlanp cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT nikloffdm cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT evansdg cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT clarker cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT lawrencehj cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT howella cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT latifa cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT ferraldeschlr cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT hillmang cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT fontecham cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy
AT newmanwg cyp2d6genotypeaffectsoutcomeinpostmenopausalbreastcancerpatientstreatedwithtamoxifenmonotherapy